Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Genset and Algene enter strategic alliance for AD research

June 2, 1999

Resubmission of ProMem NDA announced by Bayer

June 1, 1999

5-HT1A receptor agonists with good potency and selectivity designed at Pierre Fabre

June 1, 1999

Sibia Neurosciences and Lilly enter collaboration for CNS disorders

June 1, 1999

Alpha-aryl-N-alkylnitrones from Centaur useful for neurological, autoimmune, inflammatory disorders

May 31, 1999

Lilly discovers arylpiperazines acting as both 5-HT reuptake inhibitors, 5-HT1D antagonists

May 31, 1999

Potent and selective 5-HT1A receptor agonists developed at Pierre Fabre

May 31, 1999

Menarini's chiral NSAID launched in U.K.

May 31, 1999

Genistein may offer protection against ALS and stroke

May 31, 1999

Noven's transdermal patch for ADHD Rx shows promise in initial clinical study

May 31, 1999

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....